🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Main Study (CACZ885M2301): The purpose of the pivotal phase of this trial w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04-11
Trial ID
NCT01327846
Treatments Being Tested
This study was designed to assess the safety, tolerability and efficacy of ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-12
Trial ID
NCT02007252
This was a four month dose ranging study followed by a 24 to 48 month exten...
Status
Terminated
Location
Anasazi Internal Medicine
Start Date
2009-04
Trial ID
NCT00900146
Treatments Being Tested
This 8-week study is designed to determine the target dose of canakinumab (...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2008-11
Trial ID
NCT00798369
Treatments Being Tested
This study is to determine whether canakinumab is able to induce and mainta...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-06-27
Trial ID
NCT02059291
Treatments Being Tested
This study was intended to assess the safety, efficacy, and response to tre...
Status
Completed
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00504595
Treatments Being Tested
This study will evaluate the effect of ACZ885 on vascular function in patie...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-12
Trial ID
NCT00995930
The 24-week, dose-ranging, multi-center, double-blind, double-dummy, active...
Status
Completed
Location
Talbert Medical Group
Start Date
2008-12
Trial ID
NCT00819585
Treatments Being Tested
This was a Phase III study of pembrolizumab plus platinum-based doublet che...
Status
Terminated
Location
Pacific Shores Medical Group
Start Date
2018-12-21
Trial ID
NCT03631199
This study assessed the safety and efficacy of canakinumab pre-filled syrin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05
Trial ID
NCT01356602
Treatments Being Tested